|
|
Uganda
|
NDA/MAL/HDP/11529
|
PERTUZUMAB + TRASTUZUMAB
|
-
|
F. HOFFMANN - LA ROCHE KAISERAUGST, WURMISWEG CH-4303 BASEL
|
Registered
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/11530
|
PERTUZUMAB + TRASTUZUMAB
|
-
|
F. HOFFMANN - LA ROCHE KAISERAUGST, WURMISWEG CH-4303 BASEL
|
Registered
|
Details →
|
|
|
Nigeria
|
Perjeta 420 mg Concentrate for Solution for Infusion
|
Pertuzumab
|
Vaccines and Biologics
|
Intravenous
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-0025
|
Pertuzumab 1200 mg + Trastuzumab 600 mg
|
Pertuzumab 1200 mg + Trastuzumab 600 mg
|
F. HOFFMANN-LA ROCHE LTD,
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-0026
|
Pertuzumab 600 mg + Trastuzumab 600 mg
|
Pertuzumab 600 mg + Trastuzumab 600 mg
|
F. HOFFMANN-LA ROCHE LTD,
|
Registered
|
Details →
|
|
|
Nigeria
|
Phesgo 1200 mg/600 mg/15 mL
|
Pertuzumab; Trastuzumab
|
Vaccines and Biologics
|
Subcutaneous
|
Registered
|
Details →
|
|
|
Nigeria
|
Phesgo 600 mg/600 mg/10 mL
|
Pertuzumab; Trastuzumab
|
Vaccines and Biologics
|
Subcutaneous
|
Registered
|
Details →
|
|
|
Kenya
|
H2026/CTD13473/28259
|
PECTUNA
|
PERTUZUMAB
|
PHARMAMED SOLUTION LIMITED
|
Registered
|
Details →
|
|
|
Zimbabwe
|
2019/9.7/5926
|
PERJETA
|
PERTUZUMAB
|
ROCHE DIAGNOSTICS GMBH, SENDHOFERSTRASSE, 116 , MANNHEIM, GERMANY; F. HOFFMAN LA ROCHE LTD, WURMISWEG, CH-4303,, KAISERUGST, SWITZERLAND;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Ghana
|
FDA/BL/233-08012
|
PERJETA
|
PERTUZUMAB
|
ROCHE DIAGNOSTIC GmBH, MANNHEIM, GERMANY
|
3 months to expiry
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-25-159
|
Pertjeta
|
Pertuzumab
|
Roche Diagnostics GmbH
|
Registered/Compliant
|
Details →
|
|
|
Zimbabwe
|
2020/13.1/5990
|
FYCOMPA 6MG
|
PERTUZUMAB
|
KAWASHIMA FACTORY, EISAI CO., LTD, 1 KAWASHIMATKAKEHAYA-MACHI, GIFU, KAKAMIGAHARA, JAPAN; EISAI MANUAFCTURING LIMITED (EML), EUROPEAN KNOWLEDGE CENTRE, MOSQUITO WAY, HERTFODSHIRE, HERTFORDSHIRE, UNITED KINGDOM;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Zimbabwe
|
2020/13.1/5991
|
FYCOMPA 8MG
|
PERTUZUMAB
|
EISAI MANUAFCTURING LIMITED (EML), EUROPEAN KNOWLEDGE CENTRE, MOSQUITO WAY, HERTFODSHIRE, HERTFORDSHIRE, UNITED KINGDOM; KAWASHIMA FACTORY, EISAI CO., LTD, 1 KAWASHIMATKAKEHAYA-MACHI, GIFU, KAKAMIGAHARA, JAPAN;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Ghana
|
FDA/BL/255-03004
|
PHESGO
|
PERTUZUMAB/TRASTUZUMAB
|
F.HOFFMAN LA ROCHE LTD ,WURWISWEG 4303,KAISERHUEIST,SWITZERLAND
|
Valid
|
Details →
|
|
|
Ghana
|
FDA/BL/255-03005
|
PHESGO
|
PERTUZUMAB/TRASTUZUMAB
|
F HOFFMANN LA ROCHE, LIMITED WURMUSWEG, CH-4303 KAISERAUGST, SWITZERLAND
|
Valid
|
Details →
|
|
|
Kenya
|
H2022/CTD9714/21796
|
PERJETA 420MG
|
PERTUZUMAB
|
ROCHE KENYA LIMITED
|
Registered
|
Details →
|
|
|
Zimbabwe
|
2023/9.7/6394
|
PHESGO
|
PERTUZUMAB; TRASTUZUMAB
|
F. HOFFMAN LA ROCHE LTD, WURMISWEG, CH-4303,, KAISERUGST, SWITZERLAND;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Zimbabwe
|
2023/9.7/6395
|
PHESGO
|
PERTUZUMAB; TRASTUZUMAB
|
F. HOFFMAN LA ROCHE LTD, WURMISWEG, CH-4303,, KAISERUGST, SWITZERLAND;
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
Details →
|
|
|
Tanzania
|
TAN 21 HM 0223
|
Perjeta
|
Pertuzumab 420 mg/14 ml
|
Roche Diagnostics GmbH
|
Registered/Compliant
|
Details →
|
|
|
Kenya
|
H2022/CTD10124/21823
|
PHESGO 600 MG/600 MG
|
PERTUZUMAB AND TRASTUZUMAB
|
ROCHE KENYA LIMITED
|
Registered
|
Details →
|